1. Home
  2. CYPH vs SPCB Comparison

CYPH vs SPCB Comparison

Compare CYPH & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.65

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$10.30

Market Cap

63.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
SPCB
Founded
2011
1988
Country
United States
Israel
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
63.2M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
CYPH
SPCB
Price
$0.65
$10.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.8M
75.8K
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$27.13
P/E Ratio
N/A
$10.36
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$7.07
52 Week High
$3.70
$13.57

Technical Indicators

Market Signals
Indicator
CYPH
SPCB
Relative Strength Index (RSI) 44.15 44.41
Support Level $0.55 $9.88
Resistance Level $0.81 $10.86
Average True Range (ATR) 0.07 0.81
MACD 0.01 -0.11
Stochastic Oscillator 42.24 8.70

Price Performance

Historical Comparison
CYPH
SPCB

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: